List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 793 studies with search of:   "Myelodysplasia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
Conditions: Myelodysplastic Syndromes;   Leukemia, Myelomonocytic, Chronic;   Myelodysplasia;   Myelomonocytic
Interventions: Drug: Lonafarnib;   Other: Placebo
2 Recruiting A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
Condition: Myelodysplasia
Interventions: Drug: Bortezomib;   Drug: Bortezomib;   Drug: Bortezomib;   Drug: Lenalidomide
3 Recruiting Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
Condition: Myelodysplasia
Intervention: Drug: Lenalidomide + Ancestim
4 Completed Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia;   Myelodysplasia
Intervention: Biological: autologous tumor cells
5 Recruiting A Study of Decitabine, Low Dose Cytarabine and G-CSF in High-Risk Myelodysplastic Syndromes, Refractory Acute Myeloid Leukemia or Acute Myeloid Leukemia in Patients With Significant Co-Morbidities
Conditions: Myelodysplasia;   Leukemia
Intervention: Drug: decitabine, G-CSF, ARA-c
6 Terminated Study of Velcade and Thalidomide in Patients With Myelodysplasia
Condition: Myelodysplastic Syndrome
Intervention: Drug: bortezomib
7 Completed VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: hydroxyurea;   Drug: laromustine
8 Recruiting Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia
Conditions: Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation
9 Active, not recruiting Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: amifostine trihydrate;   Drug: cytarabine;   Drug: topotecan hydrochloride
10 Active, not recruiting Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methotrexate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
11 Recruiting Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
Condition: Myelodysplastic Syndromes
Intervention: Drug: VORINOSTAT
12 Active, not recruiting Decitabine in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: decitabine
13 Active, not recruiting Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: arsenic trioxide;   Drug: cholecalciferol
14 Completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: tipifarnib
15 Completed Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: cholecalciferol
16 Recruiting Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Procedure: DNA methylation analysis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: cytogenetic analysis;   Procedure: gene expression analysis;   Procedure: immunologic technique;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
17 Active, not recruiting Amifostine in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: amifostine trihydrate
18 Active, not recruiting Paricalcitol in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: paricalcitol
19 Active, not recruiting Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: anti-thymocyte globulin;   Drug: etanercept
20 Active, not recruiting Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: lenalidomide

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services